Reportstack

Newron Pharmaceuticals Product Pipeline Review 2012

 

Naperville, IL -- (ReleaseWire) -- 06/27/2012 -- Newron Pharmaceuticals Product Pipeline Review 2012 provides data on the Newron Pharmaceuticals S.p.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- Newron Pharmaceuticals S.p.A. - Brief Newron Pharmaceuticals S.p.A. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Newron Pharmaceuticals S.p.A. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Newron Pharmaceuticals S.p.A. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Newron Pharmaceuticals S.p.A.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Newron Pharmaceuticals S.p.A.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Newron Pharmaceuticals S.p.A. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Newron Pharmaceuticals S.p.A.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Newron Pharmaceuticals S.p.A..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Newron Pharmaceuticals S.p.A. and identify potential opportunities in those areas.

Keyword

Current R&D Portfolio of Newron Pharmaceuticals S.p.A.; Newron Pharmaceuticals S.p.A. - Key Therapeutics; Newron Pharmaceuticals S.p.A. - Pipeline Overview and Promising Molecules; Newron Pharmaceuticals S.p.A. - News; Newron Pharmaceuticals S.p.A. - Latest Updates; Newron Pharmaceuticals S.p.A. - Pipeline; Newron Pharmaceuticals S.p.A. - Discontinued/Dormant Projects

To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/67549/newron-pharmaceuticals-spa-product-pipeline-review-2012.html